2013-72-1

Basic information

• Product Name: 5-nitronicotinic acid chloride
• Synonyms: 5-nitronicotinic acid chloride
• CAS NO: 2013-72-1
• Molecular Weight: 186.554
• Mol File: 2013-72-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-nitronicotinic acid chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 5-nitronicotinic acid chloride(2013-72-1)
• EPA Substance Registry System: 5-nitronicotinic acid chloride(2013-72-1)

Safety Data

• Hazardous Substances Data: 2013-72-1(Hazardous Substances Data)

Upstream product

• 2047-49-6 5-nitropyridine-3-carboxylic acid 

Relevant articles and documents

PEST CONTROL COMPOSITION AND APPLICATION THEREOF

PROBLEM TO BE SOLVED: To provide a pest control composition having excellent pest control effect to pest. SOLUTION: There is provided a pest control composition containing an oxalyl amide compound represented by the formula (I) and one or more kind of component selected from the following groups (a) to (d). (I), where a ring containing J1 to J4 is a pyridine ring or the like, R1 and R3 are each independently H, a halogen atom or the like, R2 is -R7 or the like, X is each independently -R7, -OR7 or the like, R4 and R5 are each independently H, -R7 or the like, R7 is a C1-C6 chain hydrocarbon group which may have one or more halogen atom, a ring containing G1 to G5 is 1,4-oxazine, 1,4-thiazine ring or the like, n is an integer of 0 to 2. Group (a): a group consisting of insecticidal components, acaricidal components and nematicidal components. Group (b): sterilization components. Group (c): phytotoxicity mitigation components. Group (d): plant growth adjustment components. SELECTED DRAWING: None COPYRIGHT: (C)2017,JPOandINPIT

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

The present invention relates to compounds and compositions of Formula P useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The definitions of variables A, B, R2, R3, R4, Ra, Ra′, Rb, Rb′, Rc, Rd, Rd′, Re, and Re′ are provided in the disclosure. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.